Neurovascular Devices Market Size, Share & Industry Trends Analysis Report by End User, Technology, Disease Pathology, Regional Outlook and Forecast, 2022-2028

The Global Neurovascular Devices Market size is expected to reach $4.2 billion by 2028, rising at a market growth of 8.8% CAGR during the forecast period.

Neurovascular devices are used to treat neurovascular conditions. Stents, coils, and clips are examples of neurovascular devices used to treat conditions like brain aneurysms. Similar devices are used to remove blood clots from the brain's arteries and veins, which can result in life-threatening disorders like stroke. This equipment includes suction and aspiration devices. Furthermore, ischemic stroke, stenosis, aneurysm, arteriovenous malformation, and fistulas are a few other neurovascular disorders that can be treated with the help of neurovascular devices.

Central nervous system or brain vascular disorders are diagnosed and treated with interventional neurology technologies. Interventional neurology includes angiography, endovascular operations, fluoroscopy,and catheter-based procedures. For example, several neurological illnesses, such as arteriovenous malformations,cerebral aneurysm,arteriovenous fistula, intracranial stenosis, and vasculitis, can be diagnosed with catheter angiography, one of the earliest in-vivo brain vascular imaging procedures.

Due to the decreased danger and trauma involved with these treatments, minimally invasive procedures are becoming increasingly common. In addition, smaller incisions reduce postoperative pain and speed up healing, resulting in high adoption of these operations and increasing R&D in this area. To bring cutting-edge minimally invasive surgical equipment to market, several important firms are investing in R&D. One of the minimally invasive procedures that doctors highly suggest is the endovascular coiling used to treat cerebral aneurysms.

During this surgery, a microcatheter is placed via the aneurysm-containing artery in the groin area. Platinum coils are released to encourage aneurysm coagulation and stop blood from entering other parts of the brain. The considerable volume of neurovascular devices consumed, which has contributed to the market expansion, is primarily due to the fast-expanding patient population for the target disorders across the key markets.

COVID-19 Impact Analysis

The neurovascular market has suffered due to the limited accessibility of medical care for disorders other than COVID-19 globally. Another element that has a detrimental impact on the market for neurovascular devices is the scarce availability of medical personnel globally. The market has also been negatively influenced by surgeries that aren't essential and can be delayed, such as those for brain aneurysms. On the other hand, the ischemic stroke section is less affected since people who have an ischemic stroke need immediate medical intervention.

Market Growth Factors

Growing demand for minimally invasive procedures

Minimally invasive medical techniques offer more therapeutic benefits than traditional surgical procedures, including a shorter hospital stay, quicker patient recovery, increased procedure effectiveness and safety, and lower costs. Hence, market acceptability and demand for minimally invasive surgical treatments are increasing among medical professionals globally. Elderly patients are more prone to neurological and neurovascular disorders. They choose treatment methods that offer simple diagnosis, straightforward treatments, increased safety, the shortest hospital stay feasible, superior efficacy, and affordable costs. These factors are estimated to support the expansion of the neurovascular devices market in the near future.

Growing prevalence of strokes over the globe

Strokes are among the leading cause of mortality worldwide, and the prevalence is very high in the United States. Globally, there are more strokes than ever before because of an array of reasons, including growing urbanization, a sedentary lifestyle, and stress. Also, the condition significantly contributes to the annual mortality toll globally. These trends are creating a sizable patient base that has to be treated. Throughout the forecast period, it is predicted that this, along with rising patient awareness regarding the availability of treatment and reimbursement for neurovascular disorders, particularly in emerging nations, will further accelerate the expansion of the neurovascular devices market.

Market Restraining Factor

High cost to be spent on neurovascular surgeries & relative products

The high price of neurovascular procedures and equipment is a major issue that is constraining the market for neurovascular devices, particularly in emerging nations having poor reimbursement policies. In addition, the cost of maintenance and any other associated indirect charges contribute to an increase in the overall price of these devices, which in turn limits the adoption of these technologies. Due to financial constraints, freestanding ambulatory surgery centers and small hospitals are less likely to invest in costly and advanced technologies. Thus, the high cost of neurovascular procedures may decline the growth of the neurovascular devices market in the upcoming years.

Technology Outlook

Based on technology, the neurovascular devices market is segmented into embolization & coiling, cerebral balloon angioplasty & stenting systems, support devices, and neuro-thrombectomy devices. In 2021, the embolization & coiling devices segment held the highest revenue share in the neurovascular devices market. Neurovascular conditions such as carotid artery diseases, arteriovenous malformations (AVMs), and intracranial atherosclerotic diseases frequently necessitate embolization devices. In addition, other factors, including the rapid introduction of new and innovative neurovascular devices, contribute to the market's expansion.

Disease Pathology Outlook

On the basis of disease pathology, the neurovascular devices market is classified into ischemic strokes, cerebral aneurysm, carotid artery stenosis, arteriovenous malformations & fistulas and other diseases. The ischemic stroke segment acquired a substantial revenue share in the neurovascular devices market in 2021. Globally, ischemic stroke is becoming more common. To avoid ischemic stroke in patients, the American Heart Association advises using stent retrieval devices to remove blood clots. The need for neurovascular devices is expected to rise in the coming years due to the rising number of cases of ischemia.

End-user Outlook

By end user, the neurovascular devices market is bifurcated into hospitals & surgical centers, ambulatory care centers, and research laboratories & academic institutes. The ambulatory care centers segment recorded a remarkable revenue share in the neurovascular devices market in 2021. Patients' decreased wait times at ASCs are anticipated to drive the segment's significant growth during the projected period. In addition, the segment's growth is propelling due to the presence of skilled professionals in such healthcare facilities.

Regional Outlook

Region wise, the neurovascular devices market is analyzed across North America, Europe, Asia Pacific and LAMEA. In 2021, the North America region dominated the neurovascular devices market with the largest revenue share. The neurovascular devices market in North America is mainly fueled by variables such as the substantial disease burden, the increase in minimally invasive neurology treatments, and the establishment of trauma/emergency care facilities in the United States. In addition, technological advances and increased research and development activities resulting in product releases are driving regional market expansion.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Stryker Corporation, Johnson & Johnson, Terumo Corporation, Merit Medical Systems, Inc., MicroPort Scientific Corporation, Medikit Co. Ltd., and W. L. Gore & Associates, Inc.

Scope of the Study

By End-user

Hospital & Surgery Centers
Ambulatory Care Centers
Research laboratories & Academic Institutes

By Technology

Embolization & Coiling
- Embolic Coils
- Flow Diversion Devices
- Liquid Embolic Agents
Neurothrombectomy Devices
- Clot Retrievers
- Suction & Aspiration Devices
- Snares
Cerebral Balloon Angioplasty & Stenting Systems
- Carotid Artery Stents
- Embolic Protection Systems
Support Devices
- Microcatheters
- Microguidewires

By Disease Pathology

Cerebral Aneuryms
Ischemic Strokes
Cartoid Artery Stenosis
Arteriovenous Malformation & Fistulas (AVM)
Others

By Geography

North America
US
Canada
Mexico
Rest of North America

Europe
Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Asia Pacific
China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific

LAMEA
Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

Abbott Laboratories
Medtronic PLC
Stryker Corporation
Johnson & Johnson
Terumo Corporation
Merit Medical Systems, Inc.
MicroPort Scientific Corporation
Medikit Co. Ltd.
W. L. Gore & Associates, Inc.

Unique Offerings

Exhaustive coverage
The highest number of market tables and figures
Subscription-based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Neurovascular Devices Market, by End-user
1.4.2 Global Neurovascular Devices Market, by Technology
1.4.3 Global Neurovascular Devices Market, by Disease Pathology
1.4.4 Global Neurovascular Devices Market, by Geography
1.5 Research Methodology

Chapter 2. Market Overview

2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Neurovascular Devices Market by End-user

3.1 Global Hospital & Surgery Centers Market by Region
3.2 Global Ambulatory Care Centers Market by Region
3.3 Global Research laboratories & Academic Institutes Market by Region

Chapter 4. Global Neurovascular Devices Market by Technology

4.1 Global Embolization & Coiling Market by Region
4.2 Global Neurovascular Devices Market by Embolization & Coiling Type
4.2.1 Global Embolic Coils Market by Region
4.2.2 Global Flow Diversion Devices Market by Region
4.2.3 Global Liquid Embolic Agents Market by Region
4.3 Global Neurothrombectomy Devices Market by Region
4.4 Global Neurovascular Devices Market by Neurothrombectomy Devices Type
4.4.1 Global Clot Retrievers Market by Region
4.4.2 Global Suction & Aspiration Devices Market by Region
4.4.3 Global Snares Market by Region
4.5 Global Cerebral Balloon Angioplasty & Stenting Systems Market by Region
4.6 Global Neurovascular Devices Market by Cerebral Balloon Angioplasty & Stenting Systems Type
4.6.1 Global Carotid Artery Stents Market by Region
4.6.2 Global Embolic Protection Systems Market by Region
4.7 Global Support Devices Market by Region
4.8 Global Neurovascular Devices Market by Support Devices Type
4.8.1 Global Microcatheters Market by Region
4.8.2 Global Microguidewires Market by Region

Chapter 5. Global Neurovascular Devices Market by Disease Pathology

5.1 Global Cerebral Aneuryms Market by Region
5.2 Global Ischemic Strokes Market by Region
5.3 Global Cartoid Artery Stenosis Market by Region
5.4 Global Arteriovenous Malformation & Fistulas (AVM) Market by Region
5.5 Global Others Market by Region

Chapter 6. Global Neurovascular Devices Market by Region

6.1 North America Neurovascular Devices Market
6.1.1 North America Neurovascular Devices Market by End-user
6.1.1.1 North America Hospital & Surgery Centers Market by Country
6.1.1.2 North America Ambulatory Care Centers Market by Country
6.1.1.3 North America Research laboratories & Academic Institutes Market by Country
6.1.2 North America Neurovascular Devices Market by Technology
6.1.2.1 North America Embolization & Coiling Market by Country
6.1.2.2 North America Neurovascular Devices Market by Embolization & Coiling Type
6.1.2.2.1 North America Embolic Coils Market by Country
6.1.2.2.2 North America Flow Diversion Devices Market by Country
6.1.2.2.3 North America Liquid Embolic Agents Market by Country
6.1.2.3 North America Neurothrombectomy Devices Market by Country
6.1.2.4 North America Neurovascular Devices Market by Neurothrombectomy Devices Type
6.1.2.4.1 North America Clot Retrievers Market by Country
6.1.2.4.2 North America Suction & Aspiration Devices Market by Country
6.1.2.4.3 North America Snares Market by Country
6.1.2.5 North America Cerebral Balloon Angioplasty & Stenting Systems Market by Country
6.1.2.6 North America Neurovascular Devices Market by Cerebral Balloon Angioplasty & Stenting Systems Type
6.1.2.6.1 North America Carotid Artery Stents Market by Country
6.1.2.6.2 North America Embolic Protection Systems Market by Country
6.1.2.7 North America Support Devices Market by Country
6.1.2.8 North America Neurovascular Devices Market by Support Devices Type
6.1.2.8.1 North America Microcatheters Market by Country
6.1.2.8.2 North America Microguidewires Market by Country
6.1.3 North America Neurovascular Devices Market by Disease Pathology
6.1.3.1 North America Cerebral Aneuryms Market by Country
6.1.3.2 North America Ischemic Strokes Market by Country
6.1.3.3 North America Cartoid Artery Stenosis Market by Country
6.1.3.4 North America Arteriovenous Malformation & Fistulas (AVM) Market by Country
6.1.3.5 North America Others Market by Country
6.1.4 North America Neurovascular Devices Market by Country
6.1.4.1 US Neurovascular Devices Market
6.1.4.1.1 US Neurovascular Devices Market by End-user
6.1.4.1.2 US Neurovascular Devices Market by Technology
6.1.4.1.3 US Neurovascular Devices Market by Disease Pathology
6.1.4.2 Canada Neurovascular Devices Market
6.1.4.2.1 Canada Neurovascular Devices Market by End-user
6.1.4.2.2 Canada Neurovascular Devices Market by Technology
6.1.4.2.3 Canada Neurovascular Devices Market by Disease Pathology
6.1.4.3 Mexico Neurovascular Devices Market
6.1.4.3.1 Mexico Neurovascular Devices Market by End-user
6.1.4.3.2 Mexico Neurovascular Devices Market by Technology
6.1.4.3.3 Mexico Neurovascular Devices Market by Disease Pathology
6.1.4.4 Rest of North America Neurovascular Devices Market
6.1.4.4.1 Rest of North America Neurovascular Devices Market by End-user
6.1.4.4.2 Rest of North America Neurovascular Devices Market by Technology
6.1.4.4.3 Rest of North America Neurovascular Devices Market by Disease Pathology
6.2 Europe Neurovascular Devices Market
6.2.1 Europe Neurovascular Devices Market by End-user
6.2.1.1 Europe Hospital & Surgery Centers Market by Country
6.2.1.2 Europe Ambulatory Care Centers Market by Country
6.2.1.3 Europe Research laboratories & Academic Institutes Market by Country
6.2.2 Europe Neurovascular Devices Market by Technology
6.2.2.1 Europe Embolization & Coiling Market by Country
6.2.2.2 Europe Neurovascular Devices Market by Embolization & Coiling Type
6.2.2.2.1 Europe Embolic Coils Market by Country
6.2.2.2.2 Europe Flow Diversion Devices Market by Country
6.2.2.2.3 Europe Liquid Embolic Agents Market by Country
6.2.2.3 Europe Neurothrombectomy Devices Market by Country
6.2.2.4 Europe Neurovascular Devices Market by Neurothrombectomy Devices Type
6.2.2.4.1 Europe Clot Retrievers Market by Country
6.2.2.4.2 Europe Suction & Aspiration Devices Market by Country
6.2.2.4.3 Europe Snares Market by Country
6.2.2.5 Europe Cerebral Balloon Angioplasty & Stenting Systems Market by Country
6.2.2.6 Europe Neurovascular Devices Market by Cerebral Balloon Angioplasty & Stenting Systems Type
6.2.2.6.1 Europe Carotid Artery Stents Market by Country
6.2.2.6.2 Europe Embolic Protection Systems Market by Country
6.2.2.7 Europe Support Devices Market by Country
6.2.2.8 Europe Neurovascular Devices Market by Support Devices Type
6.2.2.8.1 Europe Microcatheters Market by Country
6.2.2.8.2 Europe Microguidewires Market by Country
6.2.3 Europe Neurovascular Devices Market by Disease Pathology
6.2.3.1 Europe Cerebral Aneuryms Market by Country
6.2.3.2 Europe Ischemic Strokes Market by Country
6.2.3.3 Europe Cartoid Artery Stenosis Market by Country
6.2.3.4 Europe Arteriovenous Malformation & Fistulas (AVM) Market by Country
6.2.3.5 Europe Others Market by Country
6.2.4 Europe Neurovascular Devices Market by Country
6.2.4.1 Germany Neurovascular Devices Market
6.2.4.1.1 Germany Neurovascular Devices Market by End-user
6.2.4.1.2 Germany Neurovascular Devices Market by Technology
6.2.4.1.3 Germany Neurovascular Devices Market by Disease Pathology
6.2.4.2 UK Neurovascular Devices Market
6.2.4.2.1 UK Neurovascular Devices Market by End-user
6.2.4.2.2 UK Neurovascular Devices Market by Technology
6.2.4.2.3 UK Neurovascular Devices Market by Disease Pathology
6.2.4.3 France Neurovascular Devices Market
6.2.4.3.1 France Neurovascular Devices Market by End-user
6.2.4.3.2 France Neurovascular Devices Market by Technology
6.2.4.3.3 France Neurovascular Devices Market by Disease Pathology
6.2.4.4 Russia Neurovascular Devices Market
6.2.4.4.1 Russia Neurovascular Devices Market by End-user
6.2.4.4.2 Russia Neurovascular Devices Market by Technology
6.2.4.4.3 Russia Neurovascular Devices Market by Disease Pathology
6.2.4.5 Spain Neurovascular Devices Market
6.2.4.5.1 Spain Neurovascular Devices Market by End-user
6.2.4.5.2 Spain Neurovascular Devices Market by Technology
6.2.4.5.3 Spain Neurovascular Devices Market by Disease Pathology
6.2.4.6 Italy Neurovascular Devices Market
6.2.4.6.1 Italy Neurovascular Devices Market by End-user
6.2.4.6.2 Italy Neurovascular Devices Market by Technology
6.2.4.6.3 Italy Neurovascular Devices Market by Disease Pathology
6.2.4.7 Rest of Europe Neurovascular Devices Market
6.2.4.7.1 Rest of Europe Neurovascular Devices Market by End-user
6.2.4.7.2 Rest of Europe Neurovascular Devices Market by Technology
6.2.4.7.3 Rest of Europe Neurovascular Devices Market by Disease Pathology
6.3 Asia Pacific Neurovascular Devices Market
6.3.1 Asia Pacific Neurovascular Devices Market by End-user
6.3.1.1 Asia Pacific Hospital & Surgery Centers Market by Country
6.3.1.2 Asia Pacific Ambulatory Care Centers Market by Country
6.3.1.3 Asia Pacific Research laboratories & Academic Institutes Market by Country
6.3.2 Asia Pacific Neurovascular Devices Market by Technology
6.3.2.1 Asia Pacific Embolization & Coiling Market by Country
6.3.2.2 Asia Pacific Neurovascular Devices Market by Embolization & Coiling Type
6.3.2.2.1 Asia Pacific Embolic Coils Market by Country
6.3.2.2.2 Asia Pacific Flow Diversion Devices Market by Country
6.3.2.2.3 Asia Pacific Liquid Embolic Agents Market by Country
6.3.2.3 Asia Pacific Neurothrombectomy Devices Market by Country
6.3.2.4 Asia Pacific Neurovascular Devices Market by Neurothrombectomy Devices Type
6.3.2.4.1 Asia Pacific Clot Retrievers Market by Country
6.3.2.4.2 Asia Pacific Suction & Aspiration Devices Market by Country
6.3.2.4.3 Asia Pacific Snares Market by Country
6.3.2.5 Asia Pacific Cerebral Balloon Angioplasty & Stenting Systems Market by Country
6.3.2.6 Asia Pacific Neurovascular Devices Market by Cerebral Balloon Angioplasty & Stenting Systems Type
6.3.2.6.1 Asia Pacific Carotid Artery Stents Market by Country
6.3.2.6.2 Asia Pacific Embolic Protection Systems Market by Country
6.3.2.7 Asia Pacific Support Devices Market by Country
6.3.2.8 Asia Pacific Neurovascular Devices Market by Support Devices Type
6.3.2.8.1 Asia Pacific Microcatheters Market by Country
6.3.2.8.2 Asia Pacific Microguidewires Market by Country
6.3.3 Asia Pacific Neurovascular Devices Market by Disease Pathology
6.3.3.1 Asia Pacific Cerebral Aneuryms Market by Country
6.3.3.2 Asia Pacific Ischemic Strokes Market by Country
6.3.3.3 Asia Pacific Cartoid Artery Stenosis Market by Country
6.3.3.4 Asia Pacific Arteriovenous Malformation & Fistulas (AVM) Market by Country
6.3.3.5 Asia Pacific Others Market by Country
6.3.4 Asia Pacific Neurovascular Devices Market by Country
6.3.4.1 China Neurovascular Devices Market
6.3.4.1.1 China Neurovascular Devices Market by End-user
6.3.4.1.2 China Neurovascular Devices Market by Technology
6.3.4.1.3 China Neurovascular Devices Market by Disease Pathology
6.3.4.2 Japan Neurovascular Devices Market
6.3.4.2.1 Japan Neurovascular Devices Market by End-user
6.3.4.2.2 Japan Neurovascular Devices Market by Technology
6.3.4.2.3 Japan Neurovascular Devices Market by Disease Pathology
6.3.4.3 India Neurovascular Devices Market
6.3.4.3.1 India Neurovascular Devices Market by End-user
6.3.4.3.2 India Neurovascular Devices Market by Technology
6.3.4.3.3 India Neurovascular Devices Market by Disease Pathology
6.3.4.4 South Korea Neurovascular Devices Market
6.3.4.4.1 South Korea Neurovascular Devices Market by End-user
6.3.4.4.2 South Korea Neurovascular Devices Market by Technology
6.3.4.4.3 South Korea Neurovascular Devices Market by Disease Pathology
6.3.4.5 Singapore Neurovascular Devices Market
6.3.4.5.1 Singapore Neurovascular Devices Market by End-user
6.3.4.5.2 Singapore Neurovascular Devices Market by Technology
6.3.4.5.3 Singapore Neurovascular Devices Market by Disease Pathology
6.3.4.6 Malaysia Neurovascular Devices Market
6.3.4.6.1 Malaysia Neurovascular Devices Market by End-user
6.3.4.6.2 Malaysia Neurovascular Devices Market by Technology
6.3.4.6.3 Malaysia Neurovascular Devices Market by Disease Pathology
6.3.4.7 Rest of Asia Pacific Neurovascular Devices Market
6.3.4.7.1 Rest of Asia Pacific Neurovascular Devices Market by End-user
6.3.4.7.2 Rest of Asia Pacific Neurovascular Devices Market by Technology
6.3.4.7.3 Rest of Asia Pacific Neurovascular Devices Market by Disease Pathology
6.4 LAMEA Neurovascular Devices Market
6.4.1 LAMEA Neurovascular Devices Market by End-user
6.4.1.1 LAMEA Hospital & Surgery Centers Market by Country
6.4.1.2 LAMEA Ambulatory Care Centers Market by Country
6.4.1.3 LAMEA Research laboratories & Academic Institutes Market by Country
6.4.2 LAMEA Neurovascular Devices Market by Technology
6.4.2.1 LAMEA Embolization & Coiling Market by Country
6.4.2.2 LAMEA Neurovascular Devices Market by Embolization & Coiling Type
6.4.2.2.1 LAMEA Embolic Coils Market by Country
6.4.2.2.2 LAMEA Flow Diversion Devices Market by Country
6.4.2.2.3 LAMEA Liquid Embolic Agents Market by Country
6.4.2.3 LAMEA Neurothrombectomy Devices Market by Country
6.4.2.4 LAMEA Neurovascular Devices Market by Neurothrombectomy Devices Type
6.4.2.4.1 LAMEA Clot Retrievers Market by Country
6.4.2.4.2 LAMEA Suction & Aspiration Devices Market by Country
6.4.2.4.3 LAMEA Snares Market by Country
6.4.2.5 LAMEA Cerebral Balloon Angioplasty & Stenting Systems Market by Country
6.4.2.6 LAMEA Neurovascular Devices Market by Cerebral Balloon Angioplasty & Stenting Systems Type
6.4.2.6.1 LAMEA Carotid Artery Stents Market by Country
6.4.2.6.2 LAMEA Embolic Protection Systems Market by Country
6.4.2.7 LAMEA Support Devices Market by Country
6.4.2.8 LAMEA Neurovascular Devices Market by Support Devices Type
6.4.2.8.1 LAMEA Microcatheters Market by Country
6.4.2.8.2 LAMEA Microguidewires Market by Country
6.4.3 LAMEA Neurovascular Devices Market by Disease Pathology
6.4.3.1 LAMEA Cerebral Aneuryms Market by Country
6.4.3.2 LAMEA Ischemic Strokes Market by Country
6.4.3.3 LAMEA Cartoid Artery Stenosis Market by Country
6.4.3.4 LAMEA Arteriovenous Malformation & Fistulas (AVM) Market by Country
6.4.3.5 LAMEA Others Market by Country
6.4.4 LAMEA Neurovascular Devices Market by Country
6.4.4.1 Brazil Neurovascular Devices Market
6.4.4.1.1 Brazil Neurovascular Devices Market by End-user
6.4.4.1.2 Brazil Neurovascular Devices Market by Technology
6.4.4.1.3 Brazil Neurovascular Devices Market by Disease Pathology
6.4.4.2 Argentina Neurovascular Devices Market
6.4.4.2.1 Argentina Neurovascular Devices Market by End-user
6.4.4.2.2 Argentina Neurovascular Devices Market by Technology
6.4.4.2.3 Argentina Neurovascular Devices Market by Disease Pathology
6.4.4.3 UAE Neurovascular Devices Market
6.4.4.3.1 UAE Neurovascular Devices Market by End-user
6.4.4.3.2 UAE Neurovascular Devices Market by Technology
6.4.4.3.3 UAE Neurovascular Devices Market by Disease Pathology
6.4.4.4 Saudi Arabia Neurovascular Devices Market
6.4.4.4.1 Saudi Arabia Neurovascular Devices Market by End-user
6.4.4.4.2 Saudi Arabia Neurovascular Devices Market by Technology
6.4.4.4.3 Saudi Arabia Neurovascular Devices Market by Disease Pathology
6.4.4.5 South Africa Neurovascular Devices Market
6.4.4.5.1 South Africa Neurovascular Devices Market by End-user
6.4.4.5.2 South Africa Neurovascular Devices Market by Technology
6.4.4.5.3 South Africa Neurovascular Devices Market by Disease Pathology
6.4.4.6 Nigeria Neurovascular Devices Market
6.4.4.6.1 Nigeria Neurovascular Devices Market by End-user
6.4.4.6.2 Nigeria Neurovascular Devices Market by Technology
6.4.4.6.3 Nigeria Neurovascular Devices Market by Disease Pathology
6.4.4.7 Rest of LAMEA Neurovascular Devices Market
6.4.4.7.1 Rest of LAMEA Neurovascular Devices Market by End-user
6.4.4.7.2 Rest of LAMEA Neurovascular Devices Market by Technology
6.4.4.7.3 Rest of LAMEA Neurovascular Devices Market by Disease Pathology

Chapter 7. Company Profiles

7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Medtronic PLC
7.2.1 Company overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 SWOT Analysis
7.3 Stryker Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.4 Johnson & Johnson
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental & Regional Analysis
7.4.4 Research & Development Expenses
7.5 Terumo Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.6 Merit Medical Systems, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.7 MicroPort Scientific Corporation
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Medikit Co. Ltd.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.9 W. L. Gore & Associates, Inc.
7.9.1 Company Overview

Companies Mentioned

Abbott Laboratories
Medtronic PLC
Stryker Corporation
Johnson & Johnson
Terumo Corporation
Merit Medical Systems, Inc.
MicroPort Scientific Corporation
Medikit Co. Ltd.
W. L. Gore & Associates, Inc.

Methodology

LOADING...

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€3576EUR$3,600USD£2,974GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€4292EUR$4,320USD£3,568GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€6008EUR$6,048USD£4,996GBP